On the 2025 ASCO Annual Assembly, Dr. Emre Yekedüz, a medical oncologist and analysis fellow at Dana-Farber Most cancers Institute, emphasised that the...
Dr. Alexandra Zaleta discusses how most most cancers sufferers face prior authorization delays, regardless of 95% being authorized, highlighting the necessity for reform.Many...
Dr. Breelyn Wilky, director of sarcoma medical oncology on the College of Colorado Most cancers Heart, encourages sufferers with gastrointestinal stromal tumors (GIST)...
